MCHP
58
3
MMM
32
2
PWR
74
3
WAT
59
4
APA
32
2
ROP
65
2
NRG
80
3
DVA
76
-7
WY
39
3
MHK
55
2
NUE
44
5
CPB
44
-5
NTAP
73
6
CA
36
16
AMGN
63
6
CLX
46
2
ICE
62
7
PH
69
2
PNR
63
3
AMP
72
3
MCHP
58
3
MMM
32
2
PWR
74
3
WAT
59
4
APA
32
2
ROP
65
2
NRG
80
3
DVA
76
-7
WY
39
3
MHK
55
2
NUE
44
5
CPB
44
-5
NTAP
73
6
CA
36
16
AMGN
63
6
CLX
46
2
ICE
62
7
PH
69
2
PNR
63
3
AMP
72
3
Financhill
Back

Penumbra Vs. Protalix BioTherapeutics Industry Stock Comparison

Buy
71

PEN
Penumbra

Last Price:
208.72
Seasonality Move:
8.63%
Sell
36

PLX
Protalix BioTherapeutics

Last Price:
1.15
Seasonality Move:
0.76%
Buy
71
Penumbra (PEN) is a Buy

Is Penumbra a Buy, Sell or Hold?

  • The current Penumbra [PEN] share price is $208.55. The Score for PEN is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • PEN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Protalix BioTherapeutics (PLX) is a Sell

Is Protalix BioTherapeutics a Buy, Sell or Hold?

  • The current Protalix BioTherapeutics [PLX] share price is $1.14. The Score for PLX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PLX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PEN Stock Price Chart

What is Penumbra's stock price today?

  • The Penumbra share price today is $208.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PEN is experiencing slight buying pressure.

PLX Stock Price Chart

What is Protalix BioTherapeutics's stock price today?

  • The Protalix BioTherapeutics share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.

PEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.67 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 85566 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (202.97 - 218.15) Sell
Bollinger Bands (100): (217.87 - 258.69) Sell

PLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 42.28 Sell
Chaikin Money Flow: -147291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.14 - 1.24) Sell
Bollinger Bands (100): (1.25 - 1.65) Sell

PEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 204.31 Buy
20-day SMA: 209.03 Sell
50-day SMA: 222.79 Sell
200-day SMA: 239.49 Sell
8-day EMA: 205.27 Buy
20-day EMA: 209.17 Sell
50-day EMA: 220.64 Sell
200-day EMA: 238.57 Sell

PLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.17 Sell
20-day SMA: 1.19 Sell
50-day SMA: 1.3 Sell
200-day SMA: 1.55 Sell
8-day EMA: 1.17 Sell
20-day EMA: 1.19 Sell
50-day EMA: 1.28 Sell
200-day EMA: 1.51 Sell

Penumbra Earnings Growth & PEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.79 per share, and an increase next year of $1.02 per share.

Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Penumbra Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protalix BioTherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):